Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis
about
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA)Elevated expression of squamous cell carcinoma antigen (SCCA) is associated with human breast carcinoma.Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer.Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer.Clinical Usefulness of Serum CYFRA 21-1 in Patients with Colorectal Cancer.The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung CancerDevelopment of transcriptomic biomarker signature in human saliva to detect lung cancerDiscovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.Time-varying pattern of postoperative recurrence risk of early-stage (T1a-T2bN0M0) non-small cell lung cancer (NSCLC): results of a single-center study of 994 Chinese patients.A multi-analyte serum test for the detection of non-small cell lung cancer.Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancerQuantifying the expression of tumor marker genes in lung squamous cell cancer with RNA sequencing.Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometryDifferential diagnostic CYFRA 21-1 level for benign and malignant pleural effusions: a meta-analysis in the Chinese population.Urinary protein biomarkers in the early detection of lung cancer.Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancerSerum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured.Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.Strategies to endow cytotoxic T lymphocytes or natural killer cells with antibody activity against carcinoembryonic antigen.Serum biomarker profiles as diagnostic tools in lung cancer.Analysis of second-harmonic-generation microscopy in a mouse model of ovarian carcinoma.Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinibPrognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinibChronic nasal exposure to nanoparticulate TiO2 causes pulmonary tumorigenesis in male mice.Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer.Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinomaPhase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancerBiomarkers in cancer screening, research and detection: present and future: a review.Increased Plasma miRNA-30a as a Biomarker for Non-Small Cell Lung Cancer.Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.Oncogene and tumor-suppressor gene products as serum biomarkers in occupational-derived lung cancer.Expression of Chemokine XCL2 and CX3CL1 in Lung CancerCirculating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted SequencingCirculating tumor DNA detection in lung cancer patients before and after surgeryInfluence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer.
P2860
Q27853357-FD787165-4A36-441A-9487-B866E8914672Q28394161-38F2497C-3E90-4C97-98D6-24CC9B1856D7Q30432609-B271D387-FC4A-49A3-9D92-A7634E943932Q30951893-4B8BA0BC-C96A-4332-B508-6C0D4CF16E78Q33400716-06D94C42-8E1A-4A65-8DDA-2A6B301732DAQ33669921-37301B1F-6E10-4971-8F45-A488A6944889Q33747929-679F4E96-176C-4D85-A736-6AE892837EA1Q34000934-3447BABC-CD90-4BDC-BD7A-05586E896736Q34030497-05BE9B2B-D740-4C27-BE34-32F5755F7A58Q34094060-788E3048-0FAB-4AF8-8AA6-7883D42D3244Q34155998-39755EEA-A740-4D3E-BFF2-46611E7DCE0BQ34255948-C9E84567-0CAD-4EC9-B657-0A71B20EF94CQ34407180-38E840A7-A4E6-4F64-8300-73050360BC33Q34430598-49E1C694-EF60-462F-B99D-5B8869B5FF36Q34434036-F86D20D6-0A47-48B9-89EE-4FFDED7A5D6FQ34489543-E26C69D6-B61B-42D4-84E4-DA9D42504BCEQ35044516-37A56C82-07C5-4928-820F-CD885AAB73C1Q35104929-0D9CCC0F-F0C6-4E60-858E-B82382582AF8Q35633965-F762D417-8FF4-4EE0-8FEC-65E9510BBEE9Q35885064-CACC513D-6429-4408-A093-1BF37E6E56D2Q35906657-5B2C995B-9E45-46B3-8C0C-74FA0CA6B6CDQ35909576-4023FE3F-7BFF-4FCD-BF73-6A81FD48297CQ35958288-83B86BEE-E6D2-46C3-BF82-58FA28AC0043Q35959307-DA7A2695-F885-4D85-8EA4-9CD9EB153E0BQ36016138-24FD4E07-BFA1-40F9-98D4-32206B870A31Q36075663-EB48EF70-AFFB-4CE8-84BC-9CDD7121803BQ36178093-13040BA5-9B5D-4D4C-A6AC-5C53CBC8141DQ36230768-4C0D5681-5B1F-4197-8AB5-9EBBBF5008F5Q36253580-12F521B6-5A4C-48B8-9AC7-96CED4A18A42Q36283286-E425C112-2833-40E5-A44B-70C857F78A5CQ36287463-1BA7BB9A-FE91-4764-80F8-4E260A7D7EE5Q36352822-086D7C3D-AB08-43F4-A162-6F55FBCA7AAEQ36590935-60F561DC-E917-44C6-9B65-8AC7DBFE5393Q36630663-0B73EAC8-1638-4769-8F5A-B4C15A2E4A9DQ36661979-71A01551-67B8-408E-91CF-302BE89956C0Q36950436-98A7D6A8-7F27-43A3-A8A1-5D1D13453F63Q37024962-7BDE9E88-882F-4369-A523-A8AC2CB7129BQ37198902-02723A5D-61C5-492E-8864-421945A43DEDQ37264643-F9224CD9-0A55-4333-A765-0B70BC8612C8Q37286453-7014D6BA-B201-4006-9238-394D393CF6DB
P2860
Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2003
@uk
name
Tumor Markers (CEA, CA 125, CY ...... ogical Diagnosis and Prognosis
@en
Tumor Markers (CEA, CA 125, CY ...... ogical Diagnosis and Prognosis
@nl
type
label
Tumor Markers (CEA, CA 125, CY ...... ogical Diagnosis and Prognosis
@en
Tumor Markers (CEA, CA 125, CY ...... ogical Diagnosis and Prognosis
@nl
prefLabel
Tumor Markers (CEA, CA 125, CY ...... ogical Diagnosis and Prognosis
@en
Tumor Markers (CEA, CA 125, CY ...... ogical Diagnosis and Prognosis
@nl
P2093
P356
P1433
P1476
Tumor Markers (CEA, CA 125, CY ...... ogical Diagnosis and Prognosis
@en
P2093
A. Marquez
E. Barreiro
N. Viñolas
P. Viladiu
R. Fuentes
P2888
P304
P356
10.1159/000074432
P577
2003-01-01T00:00:00Z
P6179
1052074677